{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:26:49Z","timestamp":1790116009312,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.amjcard.2025.12.012","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T16:42:01Z","timestamp":1767631321000},"page":"43-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Procedural Complexity and Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"263","author":[{"given":"Ridhima","family":"Goel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Spirito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Sweeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Hooda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parasuram Melarcode","family":"Krishnamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman","family":"Baber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapoorna","family":"Kini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George D","family":"Dangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5546-262X","authenticated-orcid":false,"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2025.12.012_bib0001","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/CIRCULATIONAHA.116.022061","article-title":"Treatment of higher-risk patients with an indication for revascularization: evolution within the field of contemporary percutaneous coronary intervention","volume":"134","author":"Kirtane","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0002","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcin.2021.09.039","article-title":"Defining percutaneous coronary intervention complexity and risk: an analysis of the United Kingdom BCIS database 2006-2016","volume":"15","author":"Protty","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0003","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.118.034456","article-title":"Newer-generation ultrathin strut drug-eluting stents versus older second-generation thicker strut drug-eluting stents for coronary artery disease","volume":"138","author":"Bangalore","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0004","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.123.013263","article-title":"Antiplatelet de-escalation strategies in patients undergoing percutaneous coronary intervention","volume":"17","author":"Spirito","year":"2024","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0005","first-page":"419","article-title":"Recent advances in antiplatelet therapy in complex percutaneous coronary intervention","volume":"11","author":"Spirito","year":"2022","journal-title":"Interv Cardiol Clin"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0006","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.jacc.2016.07.760","article-title":"Efficacy and safety of dual antiplatelet therapy after complex PCI","volume":"68","author":"Giustino","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0007","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.jacc.2017.09.011","article-title":"Lesion complexity and outcomes of extended dual antiplatelet therapy after percutaneous coronary intervention","volume":"70","author":"Yeh","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0008","first-page":"804","article-title":"Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical event Reduction in Acute Coronary Syndrome (TRACER) randomized trial","volume":"38","author":"Valgimigli","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0009","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1908419","article-title":"Ticagrelor with or without Aspirin in high-risk patients after PCI","volume":"381","author":"Mehran","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0010","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCULATIONAHA.119.040167","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention","volume":"140","author":"Urban","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0011","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.jacc.2020.03.070","article-title":"Validation of the academic research consortium high bleeding risk definition in contemporary PCI patients","volume":"75","author":"Cao","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0012","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1093\/eurheartj\/ehaa671","article-title":"Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk","volume":"41","author":"Corpataux","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0013","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10557-020-07009-6","article-title":"Tailoring dual antiplatelet therapy for the complex PCI patient: current status and perspectives","volume":"34","author":"Benetou","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0014","article-title":"Unravelling the puzzle of antithrombotic therapies for complex percutaneous coronary intervention","author":"De Luca","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0015","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.jacc.2020.03.011","article-title":"Ticagrelor with or without aspirin after complex PCI","volume":"75","author":"Dangas","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0016","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/ehjcvp\/pvad069","article-title":"Predictive value of the thrombotic risk criteria proposed in the 2023 ESC guidelines for the management of ACS: insights from a large PCI registry","volume":"10","author":"Spirito","year":"2024","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0017","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jcin.2023.02.005","article-title":"Validation of UK-BCIS CHIP score to predict 1-year outcomes in a contemporary United States population","volume":"16","author":"Khandelwal","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0018","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ahj.2023.04.007","article-title":"Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: insights from a large PCI registry","volume":"263","author":"Spirito","year":"2023","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0019","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jcin.2015.12.013","article-title":"Safety and efficacy of new-generation drug-eluting stents in women undergoing complex percutaneous coronary artery revascularization: from the WIN-DES collaborative patient-level pooled analysis","volume":"9","author":"Giustino","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0020","unstructured":"National Cardiovascular Data Registry (NCDR), NCDR CathPCI Registry v4.4, 2011, Coder\u2019s Data Dictionary: American College of Cardiology. Available at:https:\/\/www.ncdr.com\/WebNCDR\/docs\/default-source\/public-data-collection-documents\/cathpci_v4_codersdictionary_4-4.pdf, (last accessed August 2025)."},{"key":"10.1016\/j.amjcard.2025.12.012_bib0021","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamacardio.2020.6814","article-title":"Assessing the risks of bleeding vs thrombotic events in patients at high bleeding risk after coronary stent implantation: the ARC-high bleeding risk trade-off model","volume":"6","author":"Urban","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0022","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41569-021-00598-1","article-title":"Bleeding avoidance strategies in percutaneous coronary intervention","volume":"19","author":"Capodanno","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0023","first-page":"1","article-title":"What do we mean by complex percutaneous coronary intervention? An assessment of agreement amongst interventional cardiologists for defining complexity","volume":"102","author":"Rjoob","year":"2023","journal-title":"Catheter Cardiovasc Interven"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0024","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.amjcard.2025.05.022","article-title":"Five years after ARCHBR's global introduction: a prospective validation study in Egypt","volume":"252","author":"El-Amrawy","year":"2025","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0025","first-page":"346","article-title":"SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease","volume":"96","author":"Riley","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0026","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/ehjcvp\/pvac071","article-title":"Efficacy and safety of P2Y12 inhibitor monotherapy after complex PCI: a collaborative systematic review and meta-analysis","volume":"9","author":"Nicolas","year":"2023","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0027","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jacc.2018.11.048","article-title":"Dual antiplatelet therapy duration based on ischemic and bleeding risks after coronary stenting","volume":"73","author":"Costa","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0028","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1916370","article-title":"Health-status outcomes with invasive or conservative care in coronary disease","volume":"382","author":"Spertus","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0029","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14303","article-title":"Percutaneous coronary revascularization versus medical therapy in chronic coronary syndromes: an updated meta-analysis of randomized controlled trials","volume":"54","author":"Panuccio","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jacasi.2022.09.011","article-title":"Clopidogrel monotherapy after 1-month DAPT in patients with high bleeding risk or complex PCI","volume":"3","author":"Yamamoto","year":"2023","journal-title":"JACC Asia"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0031","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1093\/eurheartj\/ehac284","article-title":"Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis","volume":"43","author":"Valgimigli","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0032","first-page":"583","article-title":"Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: analysis from the Onyx ONE clear study","volume":"99","author":"Kandzari","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0033","first-page":"E758","article-title":"Ischemic and bleeding risk after complex percutaneous coronary intervention in patients with or without high bleeding risk","volume":"97","author":"Yamamoto","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0034","doi-asserted-by":"crossref","first-page":"e418","DOI":"10.4244\/EIJ-D-18-00293","article-title":"Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial","volume":"14","author":"Lipiecki","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0035","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jacc.2023.04.003","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"82","author":"Virani","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0036","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12872-020-01600-3","article-title":"Contribution of ESC DAPT guideline-endorsed high thrombotic risk features to long-term clinical outcomes among patients with and without high bleeding risk after PCI","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0037","first-page":"1111","article-title":"Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stents","volume":"98","author":"Goel","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2025.12.012_bib0038","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jacc.2022.11.041","article-title":"P2Y(12) inhibitor monotherapy or dual antiplatelet therapy after complex percutaneous coronary interventions","volume":"81","author":"Gragnano","year":"2023","journal-title":"J Am Coll Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914925007441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914925007441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:54:40Z","timestamp":1773939280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914925007441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":38,"alternative-id":["S0002914925007441"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2025.12.012","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Procedural Complexity and Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2025.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}